Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5277
Source ID: NCT00111670
Associated Drug: Dpp-Iv Inhibitor
Title: A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: DPP-IV Inhibitor|DRUG: Placebo
Outcome Measures: Primary: Absolute change from baseline in HbAlc\n\n, Week 12 | Secondary: Absolute change in FPG and absolute/relative change in insulin sensitivity, beta-cell-function, lipid profile, response rate, Week 12|AEs, vital signs, laboratory tests, body weight, waist/hip ratio, ECG\n, Throughout study
Sponsor/Collaborators: Sponsor: Hoffmann-La Roche
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 291
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2005-06
Completion Date: 2006-07
Results First Posted:
Last Update Posted: 2016-11-02
Locations: Salinas, California, 93901, United States|Clearwater, Florida, 33765, United States|Hialeah, Florida, 33013, United States|Pembroke Pines, Florida, 33029, United States|Blue Ridge, Georgia, 30513, United States|Aurora, Illinois, 60504, United States|Elkton, Maryland, 21921, United States|Oxon Hill, Maryland, 20745, United States|Troy, Michigan, 48098, United States|Pahrump, Nevada, 89048, United States|Cincinnati, Ohio, 45224, United States|Portland, Oregon, 97239, United States|Warminster, Pennsylvania, 18974, United States|Dallas, Texas, 75246, United States|Midland, Texas, 79707, United States|San Antonio, Texas, 78229, United States|Richmond, Virginia, 23249, United States|Virginia Beach, Virginia, 23451, United States|Ruse, 7002, Bulgaria|Sofia, 1233, Bulgaria|Sofia, 1606, Bulgaria|San Jose, 755-1000, Costa Rica|Tartu, 50406, Estonia|Tartu, 51014, Estonia|Ogre, 5001, Latvia|Riga, 1002, Latvia|Klaipeda, 92304, Lithuania|Vilnius, 08661, Lithuania|Chihuahua, 31238, Mexico|Guadalajara, 44340, Mexico|Guadalajara, 44650, Mexico|Mexico City, 06726, Mexico|Mexico City, 14000, Mexico|Monterrey, 64460, Mexico|Pachuca, 42086, Mexico|Ponce, 00716, Puerto Rico|Bucharest, 020475, Romania|Cluj-napoca, 400006, Romania|Ploiesti, 100163, Romania|Tirgu-mures, 540011, Romania
URL: https://clinicaltrials.gov/show/NCT00111670

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress